Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Meridian Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
Annualized+11.21%
Digest Analysis
Quick Take
"Meridian Growth Fund outperformed its small-cap growth benchmark despite negative returns, demonstrating effective downside protection through focus on high-quality businesses with recurring revenue."
Executive Summary
The Meridian Growth Fund returned -1.86% net in Q2 2024, outperforming its Russell 2500 Growth Index benchmark which declined -4.22%. The fund's investment strategy emphasizes three key tenets: focusing on high-quality businesses with recurring revenue and sustainable competitive advantages, prioritizing risk management over return opportunity, and building an enduring portfolio that can mitigate losses during turbulent periods while participating in upside during strong markets. The strategy's emphasis on downside protection proved effective during the quarter, outperforming on days when the index declined 2% or more. Top contributors included Transmedics Group with its revolutionary organ transplant technology, Chewy following its post-COVID correction at attractive valuations, and Agios Pharmaceuticals after positive Phase 3 trial results. The fund continues to focus on companies with consistent earnings trading at attractive valuations, contrasting with the market's appetite for expensively valued, high-momentum companies. Looking forward, the manager seeks to capitalize on market volatility while maintaining focus on high-quality companies with stable revenue streams.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
68%
CautiousHigh
Moderate (68%)
The fund demonstrates moderate-high conviction through concentrated holdings in the top 10 positions (totaling about 30% of portfolio), specific position sizing decisions including trimming on valuation discipline, and detailed thesis explanations for individual holdings. The manager shows conviction in maintaining positions through volatility while being disciplined about valuations.
Growth Outlook
38%
BearishBullish
Neutral (38%)
The manager acknowledges challenging market conditions including sustained high interest rates, increased unemployment, market concentration favoring large-cap tech, and valuation disparities. While not explicitly bearish, the tone suggests caution about the current environment with small companies struggling and limited market breadth.
Risk Appetite
0%
DefensiveAggressive
Defensive (0%)
The fund maintains its positioning with selective trimming on valuation discipline and re-establishing positions at attractive prices. The strategy emphasizes downside protection and risk management, suggesting a balanced approach rather than aggressive risk-taking or defensive positioning.
Capital Deployment
5%
De-riskingDeploying
De-risking (5%)
The fund shows minimal net deployment activity with selective trimming of appreciated positions (Transmedics, Agios) balanced by re-establishing a position in Chewy. The activity appears to be rotation-based rather than net deployment or de-risking, with maintained positions in several holdings despite volatility.
Forward Guidance
0%
CautiousExpansionary
Cautious (0%)
The manager plans to continue seeking opportunities to capitalize on market volatility while maintaining focus on high-quality companies. The approach is methodical and patient rather than showing clear directional bias toward aggressive deployment or defensive positioning.
Language Signal
45%
BearishBullish
Balanced (45%)
Language includes some cautious elements like market turbulence, volatility, and risk management emphasis, but is balanced with opportunity-focused terms like attractive valuations, compelling opportunities, and confidence in business models. Slightly more risk-aware than bullish overall.
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
The manager acknowledges moderate risks including sustained high interest rates, increased unemployment, market concentration, and valuation disparities. These risks are discussed as ongoing concerns affecting the investment environment but are not characterized as systemic or crisis-level threats.
Opportunity Density
55%
ScarceAbundant
Selective (55%)
The manager sees selective opportunities in the current environment, evidenced by re-establishing positions at attractive prices and maintaining focus on high-quality companies with compelling valuations. The approach suggests opportunities exist but require selectivity and patience rather than abundant choices.
Time Horizon
70%
Short-TermLong-Term
Decade+ (70%)
The strategy emphasizes building an enduring portfolio for long-term growth of capital with focus on sustainable competitive advantages and recurring revenue businesses. The manager shows patience in holding through volatility and waiting for attractive entry points, suggesting a multi-year investment horizon.